- Report
- October 2023
- 138 Pages
Asia Pacific
From €3697EUR$4,000USD£3,116GBP
- Report
- October 2023
- 182 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- October 2023
- 170 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- October 2023
- 84 Pages
Canada
From €3235EUR$3,500USD£2,727GBP
- Report
- October 2023
- 81 Pages
Canada
From €3235EUR$3,500USD£2,727GBP
- Report
- October 2023
- 90 Pages
India
From €3235EUR$3,500USD£2,727GBP
- Report
- August 2023
- 112 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- August 2023
- 110 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- August 2023
- 114 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- March 2023
- 112 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- December 2022
- 72 Pages
Australia
From €3235EUR$3,500USD£2,727GBP
- Report
- July 2021
- 284 Pages
Global
From €4159EUR$4,500USD£3,506GBP
- Report
- August 2022
- 143 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- January 2024
- 150 Pages
Global
From €4482EUR$4,850USD£3,779GBP
- Report
- January 2024
- 200 Pages
Global
From €3835EUR$4,150USD£3,233GBP
- Report
- October 2023
- 145 Pages
Global
From €2911EUR$3,150USD£2,454GBP
From €1936EUR$2,095USD£1,632GBP
€3688EUR$3,990USD£3,109GBP
- Report
- May 2025
United Kingdom
From €1936EUR$2,095USD£1,632GBP
€3688EUR$3,990USD£3,109GBP
- Report
- September 2022
- 252 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- July 2023
- 115 Pages
Global
From €4159EUR$4,500USD£3,506GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more